Curr Pharm Des. 2003;9(28):2317-22.

Antiplatelet therapies: platelet GPIIb/IIIa antagonists and beyond.

Source

Albany College of Pharmacy, Albany, NY 12208-3492, USA. mousas@acp.edu

Abstract

Cardiovascular and cerebrovascular diseases continue to be leading causes of death throughout the world. Blood platelets play a pivotal role not only in haemostasis but also in the pathogenesis of thrombosis and atherosclerosis, platelet aggregation being an essential step in the formation of either an effective haemostatic plug or an intravascular thrombus. The benefits of various antiplatelet therapies ranging from aspirin, ticlopidine, Clopidogrel, and intravenous platelet GPIIb/IIIa antagonists in various thromboembolic disorders are well documented. Despite of the success of intravenous acute GPIIb/IIIa blockade when given in conjunction with heparin, chronic oral GPIIb/IIIa antagonists with or without aspirin failed in various cardiovascular settings. This review highlights the role of the various antiplatelet therapies in thrombotic disorders as well as future directions.

PMID:: 14529393; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Blood Thinners - MedlinePlus Health Information

Supplemental Content

Icon for Bentham Science Publishers Ltd.

Save items

Related citations in PubMed

Review [Clopidogrel in the prevention of stroke]. [Orv Hetil. 2004]
Review [Clopidogrel in the prevention of stroke].
Nagy V, Fehér J. Orv Hetil. 2004 Dec 19; 145(51):2563-7.
Review Lotrafiban: an oral platelet glycoprotein IIb/IIIa blocker. [Expert Opin Investig Drugs. 2000]
Review Lotrafiban: an oral platelet glycoprotein IIb/IIIa blocker.
Liu F, Craft RM, Morris SA, Carroll RC. Expert Opin Investig Drugs. 2000 Nov; 9(11):2673-87.
Review Antiplatelet therapies: platelet GPIIb/IIIa antagonists and beyond. [Curr Opin Investig Drugs. 2001]
Review Antiplatelet therapies: platelet GPIIb/IIIa antagonists and beyond.
Konstantopoulos K, Mousa SA. Curr Opin Investig Drugs. 2001 Aug; 2(8):1086-92.
Review Novel platelet inhibitors. [Annu Rev Med. 2001]
Review Novel platelet inhibitors.
Bennett JS. Annu Rev Med. 2001; 52:161-84.
Differential antiplatelet effects of various glycoprotein IIb-IIIa antagonists. [Thromb Res. 2001]
Differential antiplatelet effects of various glycoprotein IIb-IIIa antagonists.
Dickfeld T, Ruf A, Pogatsa-Murray G, Müller I, Engelmann B, Taubitz W, Fischer J, Meier O, Gawaz M. Thromb Res. 2001 Jan 15; 101(2):53-64.

See reviews... See all...

Recent activity

Clear Turn Off Turn On

Antiplatelet therapies: platelet GPIIb/IIIa antagonists and beyond.
Antiplatelet therapies: platelet GPIIb/IIIa antagonists and beyond.
Curr Pharm Des. 2003 ;9(28):2317-22.

PubMed
Comparing the abuse potential of methylphenidate versus other stimulants: a revi...
Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient.
J Clin Psychiatry. 2003 ;64 Suppl 11:14-8.

PubMed
Cholesterol depletion inhibits store-operated calcium currents and exocytotic me...
Cholesterol depletion inhibits store-operated calcium currents and exocytotic membrane fusion in RBL-2H3 cells.
Biochemistry. 2003 Oct 14 ;42(40):11808-14.

PubMed
Bacterial expression, characterization, and disulfide bond determination of solu...
Bacterial expression, characterization, and disulfide bond determination of soluble human NTPDase6 (CD39L2) nucleotidase: implications for structure and function.
Biochemistry. 2003 Oct 14 ;42(40):11726-35.

PubMed
Neuropsychological deficits of a U.S. Army pilot following an anoxic event as a ...
Neuropsychological deficits of a U.S. Army pilot following an anoxic event as a function of cardiac arrest.
Mil Med. 2003 Sep ;168(9):769-71.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: